[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Baxter Healthcare Corporation\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":67},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100612697","gen-2-battrode-wear-study-100612697",false,"NCT07256951","Gen 2 Battrode Wear Study","Inclusion Criteria:\n\n1. Participant is ≥ 18 years.\n2. Completes the consent process as required.\n3. Participants can speak and read English fluently.\n4. Willing to allow shaving of device application area, as required.\n5. Willing to take photos of the application area before wear, daily during wear, and immediately after removal.\n6. Willingness to report current known pregnancy.\n\nExclusion Criteria:\n\n1. Unable to comply with the study protocol and instructions for wearing the devices for up to 15 days.\n2. Any pre-existing breached or compromised skin, skin rash, irritation or infection at the application area.\n3. Any incision, wound or scar in the application area.\n4. Participants with known skin allergies and sensitivities to adhesives.\n5. Participants with scheduled electronic imaging (including magnetic resonance imaging), cardioversion, and\u002For procedures where device would be removed during the data collection period.\n6. Participants with known history of cardiac arrhythmias.\n7. Participants with chest anatomies not compatible with secure parasternal placement.\n8. Use of clothing or garment that can dislodge or loosen the patch or bras with underwires or other worn items that might interfere with the devices under study.",true,"ALL","18 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","Validating adhesive wear time",[26],"Adhesive Wear Time","RECRUITING","2025-11-21",{"date":30,"type":31},"2025-12-01","ACTUAL",{"date":33,"type":31},"2025-11-12",{"date":35,"type":20},"2026-05-15",{"name":37,"class":38},"Baxter Healthcare Corporation","INDUSTRY",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":16,"minAge":46,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":21,"phases":49,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":39},"100588117","evaluation-of-the-effectiveness-of-the-volara-system-determined-by-sputum-movement-and-production-100588117","NCT06937216","Evaluation of the Effectiveness of The Volara System Determined by Sputum Movement and Production","Inclusion Criteria:\n\n1. Documented diagnosis of COPD with or without bronchiectasis.\n2. Age ≥ 21 years.\n3. Naive to Volara therapy.\n4. FEV1 \\\u003C 80% predicted (based on pulmonary function tests within the past 12 months).\n5. Daily sputum production over the prior 2 weeks.\n6. Signed informed consent.\n7. Stable pulmonary disease defined as no change in disease status.\n8. Stable medication regimen for 30 days prior to visit 1, defined as no change in prescribed medications and adherence to their prescribed medications for pulmonary disease\n\nExclusion Criteria:\n\n1. Anticipated requirement for hospitalisation within the next 35 days (± 1 day).\n2. History of pneumothorax within the past 6 months prior to visit 1.\n3. History of haemoptysis requiring embolization within the past 12 months prior to visit 1.\n4. Inability or unwillingness to perform Volara System therapy as directed, without healthcare provider support.\n5. Inability or unwillingness to complete study visits and\u002For provide follow-up data as required per the study protocol.\n6. Inability to complete a 6-minute walk.\n7. Actively participating in another clinical trial involving an investigational medication or device.\n8. Pregnant females as verified by point of care human chorionic gonadotropin test.\n9. Current Intrapulmonary Percussive Ventilation and\u002For oscillation and lung expansion users.\n10. Participant requires a prescribed daily regimen for airway clearance with a device or with manual therapy in addition to Volara.\n11. Participant requires mechanical ventilation.\n12. Participants with artificial airways","21 Years",{"count":48,"type":20},10,[23],"The aim of this study is to evaluate the therapeutic effect of therapy with The Volara System on mucus clearance.",[52,53],"Bronchiectasis Adult","COPD",[55,56,57],"Volara","OLE Therapy","mucous clearance","NOT_YET_RECRUITING","2025-04-15",{"date":61,"type":31},"2025-04-22",{"date":63,"type":20},"2025-05",{"date":65,"type":20},"2025-11",{"name":37,"class":38},""]